Education
About Us
Working with TipRanks
Follow Us
Instil Bio, Inc. (TIL)
NASDAQ:TIL
Total Valuation
Instil Bio has a market cap or net worth of $76.70M. The enterprise value is $125.66M.
Market Cap$76.70M
Enterprise Value$125.66M
Share Statistics
Instil Bio has 6,781,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,781,976
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Instil Bio’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -28.39%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-28.39%
Return on Capital Employed (ROCE)-0.29
Revenue Per Employee0.00
Profits Per Employee-5.30M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Instil Bio is ―. Instil Bio’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio0.73
Price to Fair Value0.73
Price to FCF-2.23
Price to Operating Cash Flow-1.69
PEG Ratio0.03
Income Statement
In the last 12 months, Instil Bio had revenue of 0.00 and earned -74.14M in profits. Earnings per share was -11.39.
Revenue0.00
Gross Profit0.00
Operating Income-73.54M
Pretax Income-74.14M
Net Income-74.14M
EBITDA-62.53M
Earnings Per Share (EPS)-11.39
Cash Flow
In the last 12 months, operating cash flow was -40.10M and capital expenditures 0.00, giving a free cash flow of -40.10M billion.
Operating Cash Flow-40.10M
Free Cash Flow-40.10M
Free Cash Flow per Share-5.91
Dividends & Yields
Instil Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta5.27
52-Week Price Change-40.44%
50-Day Moving Average14.03
200-Day Moving Average20.42
Relative Strength Index (RSI)41.51
Average Volume (3m)60.57K
Important Dates
Instil Bio upcoming earnings date is Mar 10, 2026, Before Open (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 10, 2026
Ex-Dividend Date―
Financial Position
Instil Bio as a current ratio of 15.76, with Debt / Equity ratio of <0.01%
Current Ratio15.76
Quick Ratio15.76
Debt to Market Cap0.69
Net Debt to EBITDA-1.27
Interest Coverage Ratio-8.18
Taxes
In the past 12 months, Instil Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Instil Bio EV to EBITDA ratio is -3.29, with an EV/FCF ratio of -3.63.
EV to Sales0.00
EV to EBITDA-3.29
EV to Free Cash Flow-3.63
EV to Operating Cash Flow-3.63
Balance Sheet
Instil Bio has $79.67M in cash and marketable securities with $84.92M in debt, giving a net cash position of -$5.25M billion.
Cash & Marketable Securities$79.67M
Total Debt$84.92M
Net Cash-$5.25M
Net Cash Per Share-$0.77
Tangible Book Value Per Share$26.03
Margins
Gross margin is 14.63%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin14.63%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Instil Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast1.40%